415 related articles for article (PubMed ID: 16730088)
1. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
[TBL] [Abstract][Full Text] [Related]
3. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
6. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.
Eriksen JG; Overgaard J;
Radiother Oncol; 2007 Jun; 83(3):383-8. PubMed ID: 17543403
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
8. Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.
Rademakers SE; Hoogsteen IJ; Rijken PF; Oosterwijk E; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende P; Takes R; De Bree R; van der Kogel AJ; Bussink J; Kaanders JH
Radiother Oncol; 2013 Sep; 108(3):517-22. PubMed ID: 23719582
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
van de Nieuwenhof HP; de Hullu JA; Kaanders JH; Bulten J; Massuger LF; van Kempen LC
Virchows Arch; 2010 Dec; 457(6):693-703. PubMed ID: 20890613
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers.
Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Takagi M; Hareyama M
Jpn J Clin Oncol; 2008 Jun; 38(6):402-7. PubMed ID: 18573850
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL
Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
15. Endogenous hypoxia markers: case not proven!
Mayer A; Höckel M; Vaupel P
Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
[TBL] [Abstract][Full Text] [Related]
16. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.
Bussink J; Kaanders JH; van der Kogel AJ
Radiother Oncol; 2003 Apr; 67(1):3-15. PubMed ID: 12758235
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
Rademakers SE; Hoogsteen IJ; Rijken PF; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende P; van der Kogel AJ; Bussink J; Kaanders JH
Head Neck; 2015 Feb; 37(2):171-6. PubMed ID: 24347430
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1.
De Schutter H; Barbé B; Spaepen M; Begg AC; Balm A; Gregoire V; Haustermans K; Mahy P; Vander Poorten V; Nuyts S
Radiother Oncol; 2006 Aug; 80(2):143-50. PubMed ID: 16916559
[TBL] [Abstract][Full Text] [Related]
20. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
